focus -WSS

focus

author：Wikipedia 2025-09-03 05:38:13 - browse：286

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： The Biogen Aduhelm mess could happen again

WSS

How to make the FDA’s new prescription one

Problems with a popular proposal to regulate AI in health care

Food makers to regulators: Ultra

Telehealth for opioid use disorder is lifesaving

Top private equity targets in 2023: cardiology, clinical trials, lasers

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

leisure time

focus

explore

Guidelines to prevent youth baseball injuries need more muscle

Hospitals consider fixing cancer drug shortages on their own

Hollywood unions extend contract negotiations for actors

Generate Biomedicines machine learning biotech raises $273M

How to save PrEP access — and even expand it

FDA proposes changes to key medical devices approval pathway

Medical leaders decry Supreme Court decision on affirmative action

New Covid vaccine is recommended for everyone 6 months or older

Drug repurposing or repositioning? The language matters

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

explore

FDA approves updated Covid vaccines

Padmanee Sharma of MD Anderson at center of lawsuit over credit

White House touts steps to stem shortages of cancer treatments

Food makers tried to stack nutrition panel with preferred experts

Bernie brings in new pharma CEOs to talk drug prices

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

hotspot

hotspot

Wikipedia

explore